IN2014DN02666A - - Google Patents

Info

Publication number
IN2014DN02666A
IN2014DN02666A IN2666DEN2014A IN2014DN02666A IN 2014DN02666 A IN2014DN02666 A IN 2014DN02666A IN 2666DEN2014 A IN2666DEN2014 A IN 2666DEN2014A IN 2014DN02666 A IN2014DN02666 A IN 2014DN02666A
Authority
IN
India
Prior art keywords
dioxabicyclo
octan
purin
cyclopropyl
dihydro
Prior art date
Application number
Inventor
Eleonora Kiss
Erwin Blomsma
Bruijn Serge De
E J N Remy Litjens
Original Assignee
Okapi Sciences Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okapi Sciences Nv filed Critical Okapi Sciences Nv
Publication of IN2014DN02666A publication Critical patent/IN2014DN02666A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Abstract

The present invention relates to the preparation of cyclopropane derivatives in particular 2 amino 9 [[(1S 2R) 1 2 bis(hydroxymethyl) cyclopropyl] methyl] 4 8 dihydro 1 purin 6 one especially via the [(1S 7R) 4 phenyl 3 5 dioxabicyclo[5.1.0]octan 1 yl]methanol intermediate.
IN2666DEN2014 2011-11-10 2011-11-10 IN2014DN02666A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/069826 WO2013068042A1 (en) 2011-11-10 2011-11-10 Method for preparing cyclopropane derivatives

Publications (1)

Publication Number Publication Date
IN2014DN02666A true IN2014DN02666A (en) 2015-05-15

Family

ID=45217501

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2666DEN2014 IN2014DN02666A (en) 2011-11-10 2011-11-10

Country Status (14)

Country Link
US (1) US9040699B2 (en)
EP (2) EP2776414B1 (en)
JP (1) JP6051225B2 (en)
CN (2) CN103930413B (en)
AU (1) AU2011380598B2 (en)
BR (1) BR112014008622B1 (en)
CA (2) CA2854656C (en)
ES (2) ES2574785T3 (en)
HK (1) HK1199446A1 (en)
IN (1) IN2014DN02666A (en)
MX (1) MX345545B (en)
NZ (2) NZ709587A (en)
RU (1) RU2593202C2 (en)
WO (1) WO2013068042A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014017163A8 (en) 2012-01-20 2017-07-04 Aratana Therapeutics Nv eye drops composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230349T2 (en) * 1991-03-05 2000-07-27 Ajinomoto Kk Cyclopropane derivative
JPH0680670A (en) * 1992-09-03 1994-03-22 Ajinomoto Co Inc Cyclopropane derivative and its production
KR950011530A (en) 1993-10-21 1995-05-15 도바 다다스 Cyclopropane derivatives and antiviral agents containing them
HRP940124A2 (en) * 1994-02-21 1997-10-31 Pliva Pharm & Chem Works Novel sulfonamidodioxepanes, methods of preparation, intermediates, salts and the use thereof
JP3769737B2 (en) * 1994-03-30 2006-04-26 味の素株式会社 Cyclopropane derivative and process for producing the same
JPH0841035A (en) * 1994-08-05 1996-02-13 Ajinomoto Co Inc Cyclopropane derivative and its production
JPH1129572A (en) 1997-07-10 1999-02-02 Ajinomoto Co Inc Purification of nucleic acid derivative
WO2010042030A1 (en) * 2008-10-07 2010-04-15 Medivir Ab Aspartyl protease inhibitors

Also Published As

Publication number Publication date
AU2011380598A1 (en) 2014-04-10
BR112014008622B1 (en) 2021-06-29
NZ622795A (en) 2015-12-24
CN107722009A (en) 2018-02-23
MX345545B (en) 2017-02-03
BR112014008622A8 (en) 2017-12-19
CN103930413B (en) 2017-11-03
EP2776414A1 (en) 2014-09-17
RU2593202C2 (en) 2016-08-10
ES2688058T3 (en) 2018-10-30
CN103930413A (en) 2014-07-16
CA2854656A1 (en) 2013-05-16
RU2014121521A (en) 2015-12-20
AU2011380598B2 (en) 2017-10-19
EP3020712B1 (en) 2018-07-04
HK1199446A1 (en) 2015-07-03
JP2014533250A (en) 2014-12-11
JP6051225B2 (en) 2016-12-27
BR112014008622A2 (en) 2017-04-18
NZ709587A (en) 2017-01-27
EP2776414B1 (en) 2016-03-16
CA3074794A1 (en) 2013-05-16
CA3074794C (en) 2022-04-12
US20150051394A1 (en) 2015-02-19
CA2854656C (en) 2020-04-28
EP3020712A1 (en) 2016-05-18
MX2014005376A (en) 2014-07-09
ES2574785T3 (en) 2016-06-22
CN107722009B (en) 2020-12-01
WO2013068042A1 (en) 2013-05-16
US9040699B2 (en) 2015-05-26

Similar Documents

Publication Publication Date Title
PH12015502839B1 (en) Antiviral compounds
ZA201306545B (en) 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of betasecretase (bace)
EA201490912A1 (en) DERIVATIVES [1,2,3] TRIAZOLO [4,5-D] Pyrimidine as Agonists of Cannabinoid Receptor 2
ECSP14013327A (en) COMPOUNDS WITH NEMATICIATED ACTIVITY
CO6801740A2 (en) Pyrrolo [2,3-d] pyrimidine tropomyosin-related kinase inhibitors
AU2012213775A8 (en) 7-azaindole derivatives
AU2014270524A8 (en) 2-phenylimidazo [1,2-a]pyrimidines as imaging agents
PL2696833T3 (en) A piece of furniture, such as an adjustable bed, having an adjustable platform
IN2014CN04160A (en)
HK1189223A1 (en) 3-4-dihydro-pyrrolo[1,2-a] pyrazin-1-ylamine derivatives useful as inhibitors of betasecretase(bace) (bace) 34--[12-a]-1-
UA111186C2 (en) Methods and compositions for preparing noribogaine from voacangine
GB2495802B (en) Acquisition scheme for vibroseis marine sources
IL232304A (en) [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid receptor 2
IN2014KN01491A (en)
JO3154B1 (en) Trpv4 antagonists
EP2794593B8 (en) Spiro aminic compounds as orexin antagonists
ZA201306416B (en) Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
EP2681198A4 (en) Novel small-molecules as therapeutics
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
EP2679649A4 (en) Additive for increasing toughness of marble glue
IN2014DN02666A (en)
AU2011355362A8 (en) 5-([1,2,3]Triazole-4-yl)-7H-pyrrolo[2,3-d]pyrimidine derivatives
AU2011900738A0 (en) Novel Small-Molecules as Therapeutics
UA80812U (en) ETHYL 6-THIOXO-3-(2-FURYLMETHYL)-7-CYANO-1,3,4,6-2H-PYRIDO[1,2-a][1,3,5]TRIAZINE -9-CARBOXYLATE